Ƶ

Timelier U.S. Guidelines; Spouse's Personality & CVD; 'Hostile' Cardiologists Out

— Recent developments of interest in cardiovascular medicine

Ƶ MedicalToday
Cardio Break over a computer rendering of a heart.

To facilitate more timely guideline updates, the have committed to annual guideline "maintenance" and single recommendation updating. (Journal of the American College of Cardiology)

Having a spouse with a was associated with adverse cardiovascular outcomes for patients with coronary artery disease, as well as their spouse, according to a prospective cohort study. (European Journal of Preventive Cardiology)

A large-scale study showed that men with obesity or other cardiovascular disease risk factors had compared with as early as 65 in women. (Journal of Neurology, Neurosurgery & Psychiatry)

Some routine measurements of have yet to recover from lows during the COVID-19 pandemic, a population-based cohort study in England suggested. (PLOS Medicine)

The past two decades have seen a declining trend in in young individuals, a nationwide study showed. (Circulation)

A Dutch hospital abruptly changed the leaders of its cardiology department after pacemakers were allowed present as the first surgeon and a report of "hostile" behavior. (NL Times)

Various types of all failed to boost chronic cardiovascular medication adherence in a pragmatic randomized trial. (JAMA)

Artificial intelligence (AI) applied to whole-body MRI scans in a study using data from two large Western European population-based cohort studies. (eBioMedicine)

The difference between chronological age and ECG-derived, AI-predicted age was associated with risk of (Afib), according to a multi-national study. (European Heart Journal)

The FDA approved landiolol (Rapiblyk) for the treatment of Afib and atrial flutter in the critical care setting, AOP Health announced.

A Swedish nationwide study suggested that concomitant heart failure -- but not prior myocarditis/perimyocarditis -- was linked to worse outcomes after . (Journal of the American Heart Association)

Many hospitalizations in heart failure trials are , a meta-analysis revealed. (JAMA Network Open)

Researchers identified a novel biomarker, circulating bone morphogenetic protein 10, for in chronic heart failure patients. (Heart)

Cardiovascular comorbidities did not seem to hamper the efficacy and tolerability of for patients with pulmonary arterial hypertension, according to a post hoc analysis of two phase III studies. (CHEST)

For patients who stayed event-free during 6 to 18 months of dual antiplatelet therapy after percutaneous coronary intervention, remained consistently better than aspirin, a post hoc analysis of the HOST-EXAM Extended trial showed. (JAMA Cardiology)

The novel showed promising preliminary results as a device dedicated to venous sinus thrombectomy in a pilot randomized trial. (Stroke)

A mouse study identified a protein as being key to for fetuses. (Development)

  • author['full_name']

    Nicole Lou is a reporter for Ƶ, where she covers cardiology news and other developments in medicine.